ANPHA appoints Louise Sylvan CEO
This article was originally published in Scrip
Louise Sylvan has been appointed chief executive officer of the Australian National Preventive Health Agency for five years as part of the government's national health reform agenda. Ms Sylvan was previously a productivity commissioner and is well known for her work in enhancing consumer rights in a range of areas including health.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.